The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Toxicity burden in older patients with chronic lymphocytic leukemia (CLL) receiving bendamustine with rituximab (BR) or ibrutinib (IB) regimens: Alliance A041202.
 
Amy S. Ruppert
No Relationships to Disclose
 
Sumithra J. Mandrekar
Consulting or Advisory Role - Pfizer; Pique
Other Relationship - Beigene
 
Allison M. Booth
No Relationships to Disclose
 
Wei Ding
Research Funding - Merck (Inst)
 
Nancy L. Bartlett
Consulting or Advisory Role - Seagen
Research Funding - ADC Therapeutics (Inst); Autolus (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Forty Seven (Inst); Genentech (Inst); Immune Design (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Merck (Inst); Millennium (Inst); Pharmacyclics (Inst); Seagen (Inst)
 
Danielle M. Brander
Honoraria - Abbvie; Genentech; Teva; TG Therapeutics
Consulting or Advisory Role - Abbvie; Genentech/Abbvie; Novartis; Pharmacyclics; Teva; TG Therapeutics
Travel, Accommodations, Expenses - Abbvie; Teva; TG Therapeutics
Other Relationship - Novartis
 
Steve E. Coutre
Stock and Other Ownership Interests - Abbvie/Pharmacyclics (I)
Honoraria - Janssen Oncology; Pharmacyclics
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Astellas Pharma; AstraZeneca; BeiGene; Celgene; Genentech/Roche; Gilead Sciences; Janssen Oncology; Novartis; Pharmacyclics
Research Funding - Abbvie (Inst); Acerta Pharma/AstraZeneca (Inst); Celgene (Inst); Janssen Oncology (Inst); Pharmacyclics (Inst); Takeda (Inst)
Expert Testimony - Genentech
Travel, Accommodations, Expenses - abbvie; BeiGene; Celgene; Genentech; Janssen Oncology; Pharmacyclics
 
Jennifer R. Brown
Honoraria - Abbvie; Janssen
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Celgene; Gilead Sciences; Infinity Pharmaceuticals; Janssen; Pharmacyclics; Redx Pharma; Roche/Genentech; Sun Pharma
Research Funding - Gilead Sciences
 
Sreenivasa R. Nattam
No Relationships to Disclose
 
Richard A. Larson
Consulting or Advisory Role - Abbvie; Agios; Amgen; ARIAD; Astellas Pharma; Boston Biomedical; Celgene; Curis; CVS Caremark; DAVA Pharmaceuticals; ERYTECH Pharma; Novartis; Pfizer
Research Funding - Astellas Pharma (Inst); Celgene (Inst); Daiichi Sankyo (Inst); ERYTECH Pharma (Inst); Novartis (Inst); Rafael Pharmaceuticals
Patents, Royalties, Other Intellectual Property - UpToDate
 
Harry Paul Erba
Consulting or Advisory Role - Agios; Amgen; Astellas Pharma; Celgene; Daiichi Sankyo; Glycomimetics; Immunogen; Incyte; Jazz Pharmaceuticals; Macrogenics; Novartis; Pfizer; Seagen
Speakers' Bureau - Agios; Celgene; Incyte; Jazz Pharmaceuticals; Novartis
Research Funding - Abbvie
Other Relationship - Celgene; Glycomimetics
(OPTIONAL) Uncompensated Relationships - Daiichi Sankyo
 
Mark Robert Litzow
Consulting or Advisory Role - Newlink Genetics; Sanofi
Research Funding - Abbvie; Abbvie/Genentech; Actinium Pharmaceuticals; Amgen; Astellas Pharma; Pluristem Therapeutics; Tolero Pharmaceuticals
 
Carolyn Owen
No Relationships to Disclose
 
Charles S. Kuzma
No Relationships to Disclose
 
Jeremy S. Abramson
Consulting or Advisory Role - Abbvie; Alimera Sciences; Alimera Sciences; Bayer; Bristol-Myers Squibb; Celgene; EMD Serono; Genentech; Gilead Sciences; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Kite, a Gilead company; Merck; MorphoSys; Novartis; Verastem
Research Funding - AI Therapeutics (Inst); Celgene (Inst); Seagen (Inst)
 
Richard F. Little
No Relationships to Disclose
 
Scott E. Smith
No Relationships to Disclose
 
Richard M. Stone
Honoraria - DAVA Pharmaceuticals; Medscape; Prime Oncology; Research to Practice
Consulting or Advisory Role - Abbvie; Actinium Pharmaceuticals; Agios; Amgen; argenx; Arog; Astellas Pharma; AstraZeneca; Biolinerx; Celgene; Celgene/Jazz; Cornerstone Pharmaceuticals; Daiichi Sankyo; Gemoab; Macrogenics; Novartis; Otsuka; Pfizer; Roche/Genentech; Stemline Therapeutics; Syntrix Biosystems; Takeda; Trovagene
Research Funding - Abbvie/Genentech (Inst); Agios (Inst); Novartis (Inst)
 
John C. Byrd
Consulting or Advisory Role - Acerta Pharma; Genentech; Jazz Pharmaceuticals; Pharmacyclics
Research Funding - Acerta Pharma (Inst); Genentech (Inst); Janssen (Inst); Pharmacyclics (Inst)
 
Jennifer Ann Woyach
Consulting or Advisory Role - ArQule; AstraZeneca; Janssen; Pharmacyclics
Research Funding - Abbvie; Janssen; Karyopharm Therapeutics; Loxo; MorphoSys; Verastem